Neuroscientific Biopharmaceuticals Ltd Cash Flow Quality Index

Latest as of June 2024: 1.04x

Neuroscientific Biopharmaceuticals Ltd cash flow quality index. Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Quality Index of 1.04x as of June 2024. Operating cash flow of AU$1.62 Million exceeds net income of AU$1.55 Million, indicating high earnings quality where cash backs reported profits. See NSB financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.04x

Operating CF / Net Income

Operating Cash Flow

AU$1.62 Million

AUD

Net Income

AU$1.55 Million

AUD

Data as of

Jun 2024

Most recent filing

Cash Flow Quality Index of Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Cash flow quality index of Neuroscientific Biopharmaceuticals Ltd from 2024 to 2024. Historical Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Neuroscientific Biopharmaceuticals Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Neuroscientific Biopharmaceuticals Ltd Cash Flow Quality Index by Year (2024–2024)

Neuroscientific Biopharmaceuticals Ltd cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Neuroscientific Biopharmaceuticals Ltd. For the full cash flow conversion analysis, see NSB cash generation efficiency.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change
2024	0.14x	AU$44.25K	AU$324.21K	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.